TVTX - Travere CSL win conditional nod for kidney disease therapy in EU
2024-04-24 08:31:26 ET
More on Travere Therapeutics
- Travere Therapeutics, Inc. (TVTX) Q4 2023 Earnings Call Transcript
- Travere Therapeutics: Restructuring Away From Disaster
- Travere Therapeutics gains as EU backs kidney disease therapy
- Travere Therapeutics Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Travere Therapeutics